Your session is about to expire
← Back to Search
AMG 510 for Non-Small Cell Lung Cancer
Study Summary
This trial will test a new cancer drug on people with advanced lung cancer that has spread to the brain.
- Non-Small Cell Lung Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You may be eligible for the study if you have had other types of cancer in the past, but only if they are not expected to affect your overall health and if you have been free of those cancers for at least 3 years. The principal investigator will review your case to determine if you can participate.You have previously taken AMG-510, other drugs that target the KRAS G12C mutation, or VEGF inhibitors for treating lung cancer.You have been diagnosed with another type of cancer in the past 2 years.You may still qualify for the study if you have non-melanoma skin cancer, cervical cancer in-situ, well-differentiated thyroid cancer, or prostate cancer.
- Group 1: Dose Expansion
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the usual applications for AMG 510?
"AMG 510 is a treatment for patients with recurrent non-squamous non-small cell lung cancer, recurrent platinum-sensitive epithelial ovarian cancer, who have had one prior systemic therapy."
How many participants will this trial have in total?
"The clinical trial is still looking for patients, as detailed on the website clinicaltrials.gov. This specific study was first posted on 6/15/2022 and updated last on 6/28/2022. They are recruiting a total of 43 individuals across 1 site."
Is AMG 510 a new or experimental drug?
"AMG 510 is being studied in 384 clinical trials, 100 of which are Phase 3. Taibei, Taiwan has several ongoing trials for AMG 510, but there are a total of 20197 locations worldwide where these studies are taking place."
Are new enrollees still being accepted into the research program?
"The information available on clinicaltrials.gov shows that this trial is looking for more patients as of right now. This particular study was first announced on June 15th, 2022 and has had some updates since then (the most recent being on June 28th, 2022)."
Share this study with friends
Copy Link
Messenger